title: Mutations in the p53 and SCID genes cooperate in tumorigenesis.
abstract: DNA damage can cause mutations that contribute to cellular transformation and tumorigenesis. The p53 tumor suppressor acts to protect the organism from DNA damage by inducing either G1 arrest to facilitate DNA repair or by activating physiological cell death (apoptosis). Consistent with this critical function of p53, mice lacking p53 are predisposed to developing tumors, particularly lymphoma. The severe combined immune deficiency (scid) focus encodes the catalytic subunit of DNA protein kinase (DNA-PKcs), a protein complex that has a role in the cellular response to DNA damage. Cells from scid mice are hypersensitive to radiation and scid lymphocytes fail to develop from precursors because they are unable to properly join DNA-coding ends during antigen receptor gene rearrangement. We examined the combined effect of loss of p53 and loss of DNA-PKcs on lymphocyte development and tumorigenesis by generating p53-/- scid mice. Our data demonstrate that loss of p53 promotes T-cell development in scid mice but does not noticeably affect B lymphopoiesis. Moreover, scid cells are able to induce p53 protein expression and activate G1 arrest or apoptosis in response to ionizing radiation, indicating that DNA-PKcs is not essential for these responses to DNA damage. Furthermore, p53-/- scid double mutant mice develop lymphoma earlier than p53-/- littermates, demonstrating that loss of these two genes can cooperate in tumorigenesis. Collectively, these results provide evidence for an unsuspected role of p53 as a checkpoint regulator in early T-cell development and demonstrate that loss of an additional component of the cellular response to DNA damage can cooperate with loss of p53 in lymphomagenesis.
authors.affiliation: Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
authors.forename: M
authors.initials: M
authors.lastname: Nacht
authors.forename: A
authors.initials: A
authors.lastname: Strasser
authors.forename: Y R
authors.initials: YR
authors.lastname: Chan
authors.forename: A W
authors.initials: AW
authors.lastname: Harris
authors.forename: M
authors.initials: M
authors.lastname: Schlissel
authors.forename: R T
authors.initials: RT
authors.lastname: Bronson
authors.forename: T
authors.initials: T
authors.lastname: Jacks
mesh_terms: D000818:Animals; D017209:Apoptosis; D001854:Bone Marrow Cells; D002453:Cell Cycle / Q000528:radiation effects; D002478:Cells, Cultured; D004249:DNA Damage; D051747:DNA-Activated Protein Kinase; D004268:DNA-Binding Proteins; D018507:Gene Expression Regulation, Developmental; D015322:Gene Rearrangement, B-Lymphocyte; D015329:Gene Rearrangement, T-Lymphocyte; D016158:Genes, p53; D016131:Lymphocyte Subsets / Q000166:cytology; D008223:Lymphoma / Q000235:genetics*; D051379:Mice; D008817:Mice, Mutant Strains; D016513:Mice, SCID / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics; D013950:Thymus Gland / Q000166:cytology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*
chemical_list: D004268:DNA-Binding Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016159:Tumor Suppressor Protein p53; D051747:DNA-Activated Protein Kinase; D017346:Protein Serine-Threonine Kinases